Dose-Dependent Efficacy of a Combined Standardized Extract of Fenugreek and Shatavari on Menopausal Symptoms: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study.

Womens Health Rep (New Rochelle) · 2026 · PMC13421819 · PMID 42539366

Europe PMC DOI

hedged sentence

0.0979

closest p · 2.0× alpha

0.0979

boldest claim

The sentences

a decreasing trendp = 0.0979so close (0.05 < p ≤ 0.1)

Fenavari 300 mg showed nonsignificant differences versus placebo on Day 14 but showing a decreasing trend on Days 28 ( p = 0.0979) and 56 ( p = 0.0571), despite slightly greater mean reductions.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.